LeMaitre Vascular to Present at the Canaccord Genuity 30th Annual Growth Conference
BURLINGTON, Mass., - July 30, 2010 (CRWE NEWSWIRE) - LeMaitre Vascular, Inc. (Nasdaq:LMAT - News), a provider of peripheral vascular devices and implants, announced today that it will present at the Canaccord Genuity 30th Annual Growth Conference at the InterContinental Hotel in Boston, MA. George W. LeMaitre, Chairman & CEO, will provide an update on the company on August 12, 2010 at 3:00 pm EDT.
About LeMaitre Vascular
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease. The Company’s principal executive offices are located at 63 Second Avenue, Burlington, Massachusetts 01803. Additional information can be found at http://www.lemaitre.com.
Contact:
LeMaitre Vascular, Inc.
Investor Relations
Aaron Grossman
781-221-2266
http://www.lemaitre.com
http://www.lemaitre.com/investor
******************************************************************
CRWENewswire tracks and announces stocks daily and is pleased to offer its Stock Alerts. Investors can receive FREE Stock Alerts by visiting http://www.crwenewswire.com/signup
About CRWENewswire.com
CRWENewswire.com is an independent electronic informative online financial news publication company dedicated in providing company associates, business and financial professionals with economic and investment information, as well as stock highlights. CRWENewswire.com is a division of Crown Equity Holdings, Inc.
CRWENewswire.com is not a registered investment advisor or broker-dealer. CRWENewswire.com and Crown Equity Holdings, Inc., (CRWE) affiliates, officers, directors, contractors and employees, including may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Release of Liability: Through use of this website viewing or using, you agree to hold CRWENewswire.com, and/or Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur.
Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. (read more) Rule 17B requires disclosure of payment for investor relations.
